|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2209491 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08844924.4 |
| Europos patento paraiškos padavimo data | 2008-10-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-07-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-10-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2008/064821 |
| Data | 2008-10-31 |
| (87) | Numeris | WO 2009/056634 |
| Data | 2009-05-07 |
| (30) | Numeris | Data | Šalis |
| 984827 P | 2007-11-02 | US |
| (72) |
CONG, Feng, US
RANGWALA, Shamina M., US
ETTENBERG, Seth, US
GUTH, Sabine, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | MOLECULES AND METHODS FOR MODULATING LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6 (LRP6) |
| MOLECULES AND METHODS FOR MODULATING LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6 (LRP6) |